Discovery Laboratories Downgraded to “Sell” at TheStreet (DSCO)
Discovery Laboratories (NASDAQ:DSCO) was downgraded by research analysts at TheStreet from a “hold” rating to a “sell” rating in a report released on Monday, American Banking and Market News reports.
The analysts wrote, “Discovery Laboratories (DSCO) has been downgraded by TheStreet Ratings from hold to sell. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself.”
Shares of Discovery Laboratories (NASDAQ:DSCO) traded up 8.50% during mid-day trading on Monday, hitting $1.66. The stock had a trading volume of 554,033 shares. Discovery Laboratories has a 1-year low of $1.50 and a 1-year high of $3.05. The stock has a 50-day moving average of $1.97 and a 200-day moving average of $2.22. The company’s market cap is $140.6 million.
Discovery Laboratories (NASDAQ:DSCO) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.14) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.13) by $0.01. On average, analysts predict that Discovery Laboratories will post $-0.58 earnings per share for the current fiscal year.
Separately, analysts at Roth Capital cut their price target on shares of Discovery Laboratories from $6.00 to $5.50 in a research note on Wednesday, March 19th.
Discovery Laboratories, Inc is a biotechnology company focused on creating life-saving products for critical care patients with respiratory disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.